Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Federated Wireless Update

16 May 2018 07:00

RNS Number : 2018O
Allied Minds PLC
16 May 2018
 

 

Federated Wireless jointly announces first successful testing of 4G LTE technology over CBRS spectrum in Verizon's live commercial network, demonstrating speeds of up to 790 Mbps

 

 

Boston, MA, 16 May 2018 - Allied Minds subsidiary, Federated Wireless, has announced jointly with Verizon, Ericsson and Qualcomm Technologies, Inc. (a subsidiary of Qualcomm Incorporated), the successful testing of 4G LTE technology over CBRS spectrum (Citizens Broadband Radio Service) in Verizon's live commercial network. After the successful initial trials last year and ongoing work to advance the CBRS ecosystem in Verizon's lab in Texas, this real-world deployment marks the beginning of public access to the 150 MHz bandwidth of 3.5 GHz shared spectrum which until now has been used by the federal government for radar systems.

"As more people use more wireless devices to do more things in more places, building a network to stay ahead of customer demand is crucial," said Mike Haberman, VP Network Engineering for Verizon. "This shared spectrum resource is a critical component of our strategy to add capacity to our network."

The deployment in Florida used a combination of Verizon licensed AWS and 700 MHz spectrum aggregated with 50 MHz of CBRS band 48 spectrum. The combination of these LTE Advanced features of multiple antennas, 256 QAM, and carrier aggregation across shared and licensed spectrum produced peak speeds of 790 Mbps. The deployments in Florida involved outdoor and in-building systems.

"We have been aggressively working over the past several years on deploying LTE Advanced features. We've fully deployed carrier aggregation in our licensed spectrum across our network in over 2,000 markets, and have 4X4 MIMO and 256 QAM deployed in over 810 markets nationwide for our customers," said Haberman. "Combining those features with this shared spectrum band will provide more capacity, higher peak speeds and faster throughput when accessing the network for our customers who have come to expect the latest technology and highest reliability from Verizon."

For this deployment, Ericsson provided Ericsson Radio DOT system for indoor and Radio 2208 for outdoor, Qualcomm Technologies provided the Qualcomm ® Snapdragon TM 845 mobile test device with X20 LTE for access to CBRS on mobile devices, and Federated Wireless provided the prioritization through their Spectrum Controller, a Spectrum Access System (SAS) that dynamically allocates channels within the FCC's spectrum sharing framework for this band. Ericsson also provided the domain proxy to enable the radios to communicate with the Federated Wireless Spectrum Controller.

This marks the beginning of commercial deployment of LTE on CBRS spectrum. Devices that can access the CBRS spectrum are expected in 2018.

ENDS

For more information contact:

Allied Minds plc +44 7771 872 922

Neil Pizey, Head of Corporate Development

 

FTI Consulting +44 20 3727 1000

Ben Atwell / Brett Pollard

 

About Allied Minds

Allied Minds plc (Allied Minds or the Company or the Group) is an IP commercialisation company focused on early stage company creation and development within the technology and life science sectors. With origination relationships spanning US federal laboratories, universities, and leading US corporations, Allied Minds sources, operates and funds a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Prospectus Rules, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGMKZKDGRZZ
Date   Source Headline
16th Jul 20217:00 amRNSTransaction in Own Shares
13th Jul 20217:00 amRNSTransaction in Own Shares
7th Jul 20217:00 amRNSTransaction in Own Shares
5th Jul 20217:00 amRNSTransaction in Own Shares
2nd Jul 20217:00 amRNSTransaction in Own Shares
1st Jul 20217:00 amRNSTransaction in Own Shares
30th Jun 20217:00 amRNSTransaction in Own Shares
29th Jun 20217:00 amRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in own shares
25th Jun 20217:00 amRNSTransaction in own shares
24th Jun 20217:00 amRNSTransaction in own shares
23rd Jun 20217:00 amRNSPortfolio company update and share buyback
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:36 pmRNSPrice Monitoring Extension
3rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSOcuTerra Therapeutics Series B Second Close
24th May 20214:41 pmRNSSecond Price Monitoring Extn
24th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20214:40 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20215:28 pmRNSResult of AGM
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
11th May 20217:00 amRNSBlock listing Interim Review
28th Apr 20217:00 amRNSOcuTerra Therapeutics Raises Series B Financing
15th Apr 20217:00 amRNSBlock Listing Application
13th Apr 20217:00 amRNSOrbital Sidekick Closes $16m Series A Financing
9th Apr 20217:00 amRNSCapital Markets Day
6th Apr 20217:00 amRNSNotice of AGM
1st Apr 20215:34 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSAnnual results release
29th Mar 20214:28 pmRNSHolding(s) in Company
22nd Mar 20217:00 amRNSNotice of results - update
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20219:00 amRNSNotice of Results
23rd Feb 20217:00 amRNSBridgeComm Advances Development of MOCA Technology
2nd Feb 20219:33 amRNSDirector/PDMR Shareholding
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSDirectorate Change
8th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20215:15 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSStrategic update
24th Dec 20207:00 amRNSOrbital Sidekick Series A Financing
21st Dec 20203:25 pmRNSFederated Wireless partners with TESSCO
1st Dec 20203:35 pmRNSTotal Voting Rights
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSShareholder engagement update on 2020 AGM vote

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.